Low-Intensity Laser & LED Therapy : A Drug-Free Option for Musculoskeletal Pain Relief
- Julian Simpson
- 5 days ago
- 3 min read
Low-Intensity Laser & LED Therapy (Photobiomodulation): A Drug-Free Option for Musculoskeletal Pain Relief
Pain is one of the most common reasons people seek healthcare, and musculoskeletal conditions such as back pain, knee injuries, neck pain, and arthritis are among the leading causes of long-term disability and reduced quality of life. While medications—particularly anti-inflammatories and opioids—are commonly used, they often come with side effects or fail to address the underlying tissue dysfunction.
Photobiomodulation therapy (PBMT), using low-intensity laser and LED light, is emerging as a safe, non-invasive, and drug-free approach to supporting pain relief and tissue recovery.
What is Photobiomodulation Therapy?
Photobiomodulation therapy (PBMT) uses specific wavelengths of red and near-infrared light delivered through low-intensity lasers or LEDs. Unlike surgical or high-power lasers, PBMT does not heat or damage tissue.
Instead, it works at a cellular level by stimulating mitochondria—the energy-producing structures in cells—to enhance healing, reduce inflammation, and regulate pain signalling.
How PBMT Works in the Body
Research suggests PBMT influences several biological processes:
Improves cellular energy (ATP production)
Reduces inflammatory markers
Enhances tissue repair and regeneration
Modulates nerve signalling involved in pain perception
Supports circulation and healing in damaged tissues
At a neurological level, PBMT may help reduce pain signalling from peripheral nerves, contributing to short-term and ongoing analgesic effects.
Conditions Where PBMT Has Shown Benefit
Evidence suggests PBMT may help reduce pain and improve function in a range of musculoskeletal conditions:
Knee Pain & Osteoarthritis
Studies show PBMT can reduce pain and improve mobility when used alongside rehabilitation programs.
Systematic reviews suggest PBMT can reduce both acute and chronic neck pain when applied within appropriate dosage ranges.
Results are mixed, but emerging evidence suggests potential benefits when treatment parameters are optimised.
Fibromyalgia
Some clinical trials show improvements in pain sensitivity, tender points, and overall function when PBMT is combined with exercise.
PBMT may reduce jaw pain and improve function, particularly when applied across multiple muscle groups.
Post-Surgical Pain (e.g. Hip Replacement)
Early evidence suggests PBMT may help reduce inflammation and pain following joint replacement surgery.
PBMT as Part of a Multimodal Approach
PBMT is not a standalone cure, but it fits well within a modern rehabilitation model that combines:
Manual therapy
Exercise rehabilitation
Load management
Nervous system desensitisation strategies
Lifestyle and recovery optimisation
This multimodal approach is often more effective than relying on medication alone.
Safety and Side Effects
One of the key advantages of PBMT is its safety profile. When applied correctly, studies report:
No known significant adverse effects
No tissue damage
No drug interactions
It is considered non-invasive and well tolerated.
Important Considerations: Dose Matters
PBMT follows a biphasic dose-response effect—meaning too little or too much light may reduce effectiveness.
Correct:
Wavelength selection
Energy dose per point
Treatment time
Target tissue coverage
…are all essential to achieving therapeutic results.
Final Thoughts
Low-intensity laser and LED therapy (photobiomodulation) represents a promising tool in modern musculoskeletal care. While research continues to refine optimal treatment parameters, current evidence supports its role in reducing pain and improving function across a range of conditions.
When integrated into a structured rehabilitation program, PBMT may offer a safe, drug-free option for supporting recovery and long-term musculoskeletal health.
reference
DE Oliveira MF, Johnson DS, Demchak T, Tomazoni SS, Leal-Junior EC. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions. Eur J Phys Rehabil Med. 2022 Apr;58(2):282-289. doi: 10.23736/S1973-9087.21.07236-1. Epub 2021 Dec 16. PMID: 34913330; PMCID: PMC9980499.